⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Bova (Bova UK / Bova Australia) and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Bova (Bova UK / Bova Australia)
↗London, United Kingdom
Bova is a specialized veterinary pharmaceutical manufacturer and compounding pharmacy. The company is recognized for providing high-quality, clinically relevant veterinary medicines, including sterile and non-sterile 'specials' (bespoke medications) for the veterinary market in the UK and Australia.
In 2022, Bova Australia and Bova UK were acquired by the Swedish animal health group Vimian, becoming part of their Specialty Pharma segment (Nextmune). The company is known for its commitment to cGMP (current Good Manufacturing Practice) standards and for developing novel formulations for various animal species.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Veterinary Compounding / Animal Health
SIZE & FINANCIALS
Employees:51-200
Founded:2008
Ownership:subsidiary
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Compounded formulations, Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Vimian Group
Acquired By:Vimian Group (2022-01-01)
Key Partnerships:Stokes Pharmacy (US partnership for FIP treatment), Trutina Pharmacy (Canada distribution)
COMPETITION
Position:Leader
Competitors:Zoetis, Elanco, Vetoquinol
LEADERSHIP
Key Executives:
Nick Bova - Founder & CEO
Andrew Rowe - Chief Operating Officer
Scientific Founders:Nick Bova
LINKS
Website:bova-europe.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Bova (Bova UK / Bova Australia). The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.